← Evidence map

ReviewCurrent oncology (Toronto, Ont.)2022

Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?

Liqin Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35877249